Table 1.
Patients’ characteristics and their correlations with C1qA [276] genotype
| Clinical Parameters | No.# |
Genotype |
P |
Clinical Parameters |
No.# |
Genotype |
P |
||
|---|---|---|---|---|---|---|---|---|---|
| AA | AG + GG | AA | AG/GG | ||||||
| Gender |
|
|
|
|
Bulky mass |
|
|
|
|
| Male |
83 |
24 |
59 |
0.542 |
≥10 cm |
18 |
5 |
13 |
1.000 |
| Female |
81 |
20 |
61 |
|
<10 cm |
146 |
39 |
107 |
|
| Age |
|
|
|
|
Localized |
|
|
|
|
| ≤60 |
102 |
26 |
76 |
0.620 |
yes |
25 |
7 |
18 |
0.886 |
| >60 |
62 |
18 |
44 |
|
no |
139 |
37 |
102 |
|
| B symptoms |
|
|
|
|
No Extra Nodal Site |
|
|
|
|
| positive |
62 |
14 |
48 |
0.338 |
≤1 |
122 |
31 |
91 |
0.484 |
| negative |
102 |
30 |
72 |
|
>1 |
42 |
13 |
29 |
|
| LDH |
|
|
|
|
Incidence site |
|
|
|
|
| positive |
77 |
20 |
57 |
0.816 |
lymph node |
93 |
25 |
68 |
0.986 |
| negative |
87 |
24 |
63 |
|
extralymph |
71 |
19 |
52 |
|
| β2-MG |
|
|
|
|
IPI |
|
|
|
|
| positive |
49 |
10 |
39 |
0.203 |
0~2 |
114 |
29 |
85 |
0.544 |
| negative |
106 |
32 |
74 |
|
3~5 |
50 |
15 |
33 |
|
| Stage |
|
|
|
|
Molecular subtypes |
|
|
|
|
| I~II |
75 |
19 |
56 |
0.691 |
GCB |
28 |
6 |
22 |
0.872 |
| III~IV | 89 | 25 | 39 | non-GCB | 113 | 26 | 87 | ||
Abbreviations: AA /AG/GG indicates C1qA 276 genotype; MG: microglobulin; IPI: international prognostic index; GCB: germinal center B cell.